I think PBMs--this is a really interesting hearing, okay? But if you eliminate all the profitability and all the incentives for creating new drugs, you have not really made a dent in our health-care spend.
On the recordMarch 30, 2023
Source
congress.govEditor's note · Context
Senator Johnson emphasizes the importance of profitability in drug development amidst discussions on PBMs.
Share
More from Ron Johnson
Aug 6, 2026
That's the golden goose. It's those people that take that money. They don't put it in a mattress. They invest it in businesses and grow the economy, which I would argue is the No. 1 component of the solution for all these problems…
Aug 12, 2026
I mean, fortunately, now we have Bobby Kennedy, I think gaining a little bit more control over the agency.
Aug 11, 2026
I mean, that is shocking, and they knew it. They knew it, they're not that stupid. They're just that devious to play with the statistics that way to misinform, to lie to the American public.





